| __timestamp | CRISPR Therapeutics AG | Evotec SE |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 12404000 |
| Thursday, January 1, 2015 | 12573000 | 18343000 |
| Friday, January 1, 2016 | 42238000 | 18108000 |
| Sunday, January 1, 2017 | 69800000 | 17614000 |
| Monday, January 1, 2018 | 113773000 | 35619000 |
| Tuesday, January 1, 2019 | 179362000 | 58432000 |
| Wednesday, January 1, 2020 | 266946000 | 63945000 |
| Friday, January 1, 2021 | 438633000 | 72200000 |
| Saturday, January 1, 2022 | 461645000 | 76642000 |
| Sunday, January 1, 2023 | 387332000 | 57519000 |
| Monday, January 1, 2024 | 320653000 |
Data in motion
In the rapidly evolving biotech sector, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, CRISPR Therapeutics AG and Evotec SE have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, CRISPR Therapeutics AG increased its R&D expenses by an astounding 25,500%, peaking in 2022. This surge underscores their aggressive pursuit of cutting-edge gene-editing technologies. In contrast, Evotec SE's R&D spending grew by a more modest 500% over the same period, reflecting a steady yet cautious approach to innovation. Notably, CRISPR's R&D expenses in 2023 were nearly 7 times higher than Evotec's, highlighting their divergent strategies. As the biotech landscape continues to shift, these spending patterns offer valuable insights into each company's future trajectory and potential breakthroughs.
R&D Spending Showdown: Novo Nordisk A/S vs Evotec SE
argenx SE or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Insmed Incorporated and Evotec SE
Ascendis Pharma A/S vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Alkermes plc and CRISPR Therapeutics AG
Who Prioritizes Innovation? R&D Spending Compared for Opthea Limited and Evotec SE
CRISPR Therapeutics AG vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Evotec SE
R&D Insights: How Iovance Biotherapeutics, Inc. and Evotec SE Allocate Funds
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending
R&D Insights: How BioCryst Pharmaceuticals, Inc. and Evotec SE Allocate Funds